Lung Cancer Treatment With ROS1 Fusions
Repotrectinib can overcome some ROS1 mutations that cause drug resistance. The FDA sanctioned this innovative therapy in 2023 for use as eit...
Showing posts with label ROS1-targeted drug. Show all posts
Showing posts with label ROS1-targeted drug. Show all posts
Subscribe to:
Comments (Atom)
